Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2002-2-1
pubmed:abstractText
The authors compared the efficacy and safety of three atypical antipsychotics (clozapine, olanzapine, and risperidone) with one another and with haloperidol in the treatment of patients with chronic schizophrenia or schizoaffective disorder.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0002-953X
pubmed:author
pubmed:issnType
Print
pubmed:volume
159
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
255-62
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:11823268-Adolescent, pubmed-meshheading:11823268-Adult, pubmed-meshheading:11823268-Antipsychotic Agents, pubmed-meshheading:11823268-Benzodiazepines, pubmed-meshheading:11823268-Chronic Disease, pubmed-meshheading:11823268-Clozapine, pubmed-meshheading:11823268-Double-Blind Method, pubmed-meshheading:11823268-Female, pubmed-meshheading:11823268-Haloperidol, pubmed-meshheading:11823268-Humans, pubmed-meshheading:11823268-Male, pubmed-meshheading:11823268-Middle Aged, pubmed-meshheading:11823268-Patient Admission, pubmed-meshheading:11823268-Pirenzepine, pubmed-meshheading:11823268-Psychiatric Status Rating Scales, pubmed-meshheading:11823268-Psychotic Disorders, pubmed-meshheading:11823268-Risperidone, pubmed-meshheading:11823268-Schizophrenia, pubmed-meshheading:11823268-Schizophrenic Psychology, pubmed-meshheading:11823268-Treatment Outcome
pubmed:year
2002
pubmed:articleTitle
Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
pubmed:affiliation
Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY 10982, USA. volavka@nki.rfmh.org
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Research Support, U.S. Gov't, P.H.S., Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study